NFE2L2 and glioblastoma: Based on its high expression of Nrf2 and p62, this cell line is considered to resemble the more aggressive mesenchymal subtype of glioblastoma [21]; the same authors also demonstrated that inhibition of Nrf2 and p62 by siRNAs impaired cell proliferation.